Psychiatry Drugs

Glutamate modulator (anti-craving)

Anti-craving Agent — Alcohol Relapse Prevention (GABA/Glutamate Modulator)

Melatonin Receptor Agonist / 5-HT2C Antagonist

Sedating antihistamine (phenothiazine)

Benzodiazepine (short-acting)

Atypical (Second-generation) Antipsychotic — Benzamide

Tricyclic Antidepressant (TCA)

Tricyclic Antidepressant (TCA)

Atypical Antipsychotic (Partial D2 Agonist)

Atypical (Second-generation) Antipsychotic — Sublingual

Selective Noradrenaline Reuptake Inhibitor (SNRI) — Non-stimulant ADHD Treatment

First-generation antipsychotic (butyrophenone)

Atypical Antipsychotic — D2/5-HT1A Partial Agonist (Schizophrenia / Adjunct MDD)

Partial Opioid Agonist (Opioid Substitution Therapy)

Opioid Partial Agonist — Opioid Substitution Therapy (OST)

Partial mu-agonist + opioid antagonist (opioid dependence)

Dopamine/Noradrenaline Reuptake Inhibitor (DNRI) — Smoking Cessation

Azapirone — Non-benzodiazepine Anxiolytic

5-HT₁A partial agonist (anxiolytic)

Mood Stabiliser (Sodium Channel Blocker) — Bipolar Disorder

Atypical (Second-generation) Antipsychotic — Dopamine D3/D2 Partial Agonist

Benzodiazepine (long-acting)

Long-acting benzodiazepine

Typical (First-generation) Antipsychotic — Low-potency

Typical (low-potency) antipsychotic

SSRI (Selective Serotonin Reuptake Inhibitor)

Sedative-hypnotic (thiamine analogue)

Tricyclic Antidepressant (TCA) — OCD Specialist

Tricyclic antidepressant

Benzodiazepine — Long-acting

Alpha-2 Adrenoceptor Agonist (ADHD / Opioid Withdrawal / Tic Disorders)

Atypical antipsychotic (treatment-resistant schizophrenia)

Antidote / Antihistamine

Dual orexin receptor antagonist

CNS Stimulant (ADHD / Narcolepsy)

CNS stimulant (Schedule 2 CD)

Benzodiazepine (long-acting)

Benzodiazepine (anxiolytic, sedative, muscle relaxant)

Alcohol Deterrent (Aldehyde Dehydrogenase Inhibitor)

Acetylcholinesterase inhibitor

Tricyclic antidepressant

Tricyclic antidepressant / topical antipruritic

SNRI (Serotonin-Noradrenaline Reuptake Inhibitor)

SSRI (Selective Serotonin Reuptake Inhibitor)

NMDA Receptor Antagonist (Treatment-Resistant Depression / Acute Suicidality)

Non-benzodiazepine hypnotic (Z-drug; cyclopyrrolone S-isomer of zopiclone)

SSRI (Selective Serotonin Reuptake Inhibitor)

Typical Antipsychotic (Thioxanthene) — Also Used as Low-dose Antidepressant

Typical depot antipsychotic

Long-acting benzodiazepine hypnotic

SSRI (Selective Serotonin Reuptake Inhibitor) — OCD Specialist

SSRI

Centrally acting α2A agonist

Alpha-2A Adrenoceptor Agonist (ADHD — Non-Stimulant)

Typical antipsychotic (butyrophenone)

Typical depot antipsychotic

Antihistamine (H1) — Anxiolytic / Sedative

Sedating H1 antihistamine

Tricyclic Antidepressant (TCA)

Tricyclic antidepressant

Non-selective irreversible MAOI

Mood Stabiliser (Sodium Channel Blocker) — Bipolar Depression

Phenothiazine antipsychotic / antiemetic

CNS Stimulant (Prodrug) — Schedule 2 Controlled Drug (ADHD / Binge Eating Disorder)

Amphetamine prodrug stimulant

Mood stabiliser

Mood stabiliser

Mood stabiliser (liquid)

Tricyclic antidepressant

α2 adrenergic agonist

Short-acting benzodiazepine hypnotic

Benzodiazepine — Short-acting

Short-acting benzodiazepine hypnotic

Atypical antipsychotic (inhalation)

Atypical Antipsychotic — Multimodal (Schizophrenia / Bipolar Depression)

Atypical (Second-generation) Antipsychotic

Atypical antipsychotic

Melatonin Receptor Agonist — Hypnotic

Long-acting synthetic opioid

CNS Stimulant — Schedule 2 Controlled Drug (ADHD Treatment)

CNS stimulant

Tetracyclic antidepressant

Noradrenergic and Specific Serotonergic Antidepressant (NaSSA)

RIMA (Reversible Inhibitor of Monoamine Oxidase A)

Wakefulness-Promoting Agent (Narcolepsy / OSAHS / Shift Work)

Wakefulness-promoting agent

Opioid Receptor Modulator (Alcohol Dependence — 'As-Needed' Therapy)

Opioid receptor modulator

Opioid Receptor Antagonist

Long-acting μ-opioid antagonist

Benzodiazepine Hypnotic — Long-acting

Tricyclic Antidepressant (TCA) — Active Metabolite of Amitriptyline

Atypical antipsychotic (second generation)

Atypical depot antipsychotic

Short-acting benzodiazepine

Atypical (Second-generation) Antipsychotic — Active Metabolite of Risperidone

SSRI (Selective Serotonin Reuptake Inhibitor)

First-generation antipsychotic (phenothiazine)

MAOI (Irreversible Monoamine Oxidase Inhibitor)

Atypical Antipsychotic — Selective 5-HT2A Inverse Agonist (Parkinson's Disease Psychosis)

First-generation antipsychotic (diphenylbutylpiperidine)

Alpha-2-delta Ligand (Voltage-gated Calcium Channel Modulator) — Anxiolytic

First-generation antipsychotic (aliphatic phenothiazine)

Atypical antipsychotic (second generation)

NRI (Selective Noradrenaline Reuptake Inhibitor)

Atypical Antipsychotic (D2/5-HT2A Antagonist)

SSRI (Selective Serotonin Reuptake Inhibitor)

Mood stabiliser / Antiepileptic

Herbal antidepressant (Hypericum perforatum)

First-generation antipsychotic (substituted benzamide)

Benzodiazepine Hypnotic — Schedule 3 Controlled Drug

Non-selective irreversible MAOI

SARI (Serotonin Antagonist and Reuptake Inhibitor)

Serotonin antagonist & reuptake inhibitor (SARI)

First-generation antipsychotic (piperazine phenothiazine)

Tricyclic antidepressant (sedating)

Amino acid (serotonin precursor)

α4β2 nicotinic partial agonist

Serotonin-Noradrenaline Reuptake Inhibitor (SNRI)

Multimodal Antidepressant — Serotonin Modulator

Atypical Antipsychotic — D2/5-HT2A Antagonist (Low Metabolic Risk)

Non-benzodiazepine hypnotic (Z-drug)

Non-Benzodiazepine Hypnotic (Z-Drug)

Typical Antipsychotic (Thioxanthene) — Oral and Depot Formulations